Latham & Watkins has advised Praxis Precision Medicines, Inc., and Mintz, Levin, Cohn, Ferris, Glovsky, and Popeo has advised the underwriters. Praxis Precision Medicines, Inc. (Nasdaq:...
You must be a Standard 1 Year member to access this content.
Mintz has advised the placement agents. Spruce Biosciences, Inc. has entered into a definitive securities purchase agreement for a private placement expected to generate gross proceeds...
You must be a Standard 1 Year member to access this content.
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. has advised VMG Partners, and Akerman LLP has advised Scenthound. Scenthound, a leading national dog wellness franchise, has...
You must be a Standard 1 Year member to access this content.
Mintz has advised the underwriters on the offering. uniQure N.V. (Nasdaq: QURE) has completed a public offering valued at approximately $345 million. The offering consisted of...
You must be a Standard 1 Year member to access this content.
Cooley has advised LB Pharmaceuticals on the offering, and Mintz has advised the underwriters. LB Pharmaceuticals Inc has announced the pricing of its upsized initial public...
You must be a Standard 1 Year member to access this content.
Skadden, Arps, Slate, Meagher & Flom LLP and Barnes and Thornburg LLP have advised Assembly Biosciences, Inc. on the deal, and Mintz has advised the underwriters....
You must be a Standard 1 Year member to access this content.
Goodwin Procter has advised Larimar Therapeutics, Inc. on the offering, and Mintz has advised the underwriters. Larimar Therapeutics, Inc. (Nasdaq: LRMR) has completed a public offering...
You must be a Standard 1 Year member to access this content.
Gibson, Dunn & Crutcher LLP acted as outside counsel, and Goodwin Procter LLP, as special counsel, have advised Cogent Biosciences, Inc., while Mintz has advised the...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati and Cooley LLP have advised Soleno Therapeutics, Inc. on the deal. Mintz has advised the underwriters. Soleno Therapeutics, Inc. has announced...
You must be a Standard 1 Year member to access this content.
Mintz, Levin, Cohn, Ferris, Glovsky, and Popeo has advised S2G Investments on the transaction. S2G Investments has completed a $40 million Series B financing round in...
You must be a Standard 1 Year member to access this content.
Gibson, Dunn & Crutcher advised Arrowhead Pharmaceuticals, Inc. on the transaction, while Mintz, Levin, Cohn, Ferris, Glovsky, and Popeo and Proskauer Rose advised Sixth Street. Arrowhead...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr advised Apellis Pharmaceuticals, Inc. on the deal, while Mintz, Levin, Cohn, Ferris, Glovsky, and Popeo and Proskauer Eose advised Sixth...
You must be a Standard 1 Year member to access this content.
